Fundus lesions of adenomatous polyposis

Current Opinion in Ophthalmology

Volumn 10, Issue 3, 1999, Pages 168-172

  Tiret, Anne ^a   Parc, Christine ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 5; CLINICAL FEATURE; COLON POLYPOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ELECTRON MICROSCOPY; EXON; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; OPHTHALMOLOGY; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS;

ADENOMATOUS POLYPOSIS COLI; CHROMOSOMES, HUMAN, PAIR 5; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GENES, APC; HUMANS; HYPERTROPHY; MUTATION; PIGMENT EPITHELIUM OF EYE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETINAL DISEASES;

EID: 0032988403     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199906000-00003     Document Type: Review

References (31)

1. 1 Blair NP, Trempe CL: Hypertrophy of the retinal pigment epithelium associated with Gardner's syndrome. Am J Ophthalmol 1980, 90:661-667.
2. 2 Traboulsi El, Krush AJ, Gardner EJ, Booker SV, Offerhaus GJA, Yardley JH, et al.: Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med 1987, 316:661-667.
3. 3 Tiret A, Sartral-Taiel M, Tiret E, Laroche L: Diagnostic value of fundus examination in familial adenomatous polyposis. Br J Ophthalmol 1997, 81:755-758.
4. 4 Hodgson SV, Bishop D T, Jay B: Genetic heterogeneity of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in families with familial adenomatous polyposis. J Med Genet 1994, 1:55-58.
5. 5 Olschwang S, Tiret A, Laurent-Puig L, Muleris M, Parc R, Thomas G: Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993, 75:959-968.
6. 6 Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Bsker T, et al.: Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995, 4:337-340.
7. 7 Bunyan DJ, Shea-Simonds J, Reck AC, Finnis D, Eccles DM: Genotype-phenotype correlations of new causative APC gene mutations in patients with familial adenomatous polyposis. J Med Genet 1995, 32:728-731.
8. 8 Aiello LP, Traboulsi EI: Pigmented fundus lesions in a preterm infant with familial adenomatous polyposis. Arch Ophthalmol 1993, 111:302-303.
9. 9 Berk T, Cohen Z, McLeod RS, Parker JA: Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis. Dis Colon Rectum 1988, 31:253-257.
10. 10 Polkinghorne PJ, Ritchie S, Neale K, Schoeppner G, Thomson JPS, Jay BS: Pigmented lesions of the retinal pigment epithelium and familial adenomatous polyposis. Eye 1990, 4:216-221.
11. 11 Olea JL, Mateos JM, Llompart A, Obrador A: Frequency of congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Acta Ophthalmol Scand 1996, 74:48-50.
12. 12 Ruhswurm I, Zehetmayer M, Dejaco C, Wolf B, Karner-Hanusch J: Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis. Am J Ophthalmol 1998, 125:680-686.
13. 13 Shields JA, Shields CL, Shah PG, Pastore DJ, Imperiale SM Jr: Lack of association among typical congenital hypertrophy of the retinal pigment epithelium, adenomatous polyposis, and Gardner syndrome. Ophthalmology 1992, 99:1709-1713.
14. 14 Santos A, Morales L, Hernandez-Quintela E, Jimenez-Sierra JM, Villalobos JJ, Panduro A: Congenital hypertrophy of the retinal pigment epithelium associated with familial adenomatous polyposis. Retina 1994, 14:6-9.
15. 15 Gelisken O, Yÿcel A, Gÿler K, Zorluoglu A: Ocular findings in familial adenomatous polyposis. Int Ophthalmol 1997, 21:205-208.
16. 16 Schmidt D, Jung CE, Wolff G: Changes in the retinal pigment epithelium close to retinal vessels in familial adenomatous polyposis. Graefes Arch Clin Exp Ophthalmol 1994, 232:96-102.
17. 17 Traboulsi EL, Murphy SF, De La Cruz ZC, Maumenee IH, Green R: A clinico-pathologic study of the eyes in familial adenomatous polyposis with extracolonic manifestations (Gardner's syndrome). Am J Ophthalmol 1990, 110: 550-561.
18. 18 Traboulsi EI, Apostolides J, Giardello FM, Krush AJ, Booker SV, Hamilton SR, Maumenee Hussels IE: Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis. Ophthalmic Genet 1996, 17:167-174.
19. 19 Kasner L, Traboulsi EI, De La Cruz Z, Green WR: A histopathologic study of the pigmented fundus lesions in familial adenomatous polyposis. Retina 1992, 12:35-42.
20. 20 Parker JA, Kalnins VI, Deck JHN, Cohen Z, Berk T, Sullen JB, et al.: Histopathological features of congenital fundus lesions in familial adenomatous polyposis. Can J Ophthalmol 1990, 25:159-163.
21. 21 Morton DG, Gibson J, Macdonald F, Brown R, Haydon J, Cullen R, et al.: Role of congenital hypertrophy of the retinal pigment epithelium in the predictive diagnosis of familial adenomatous polyposis. Br J Surg 1992, 79:689-693.
22. 22 Moore AT, Maher ER, Koch DJ, Charles SJ: Incidence and significance of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial adenomatous polyposis coli (FAPC). Ophthalmic Paediatr Genet 1992, 13: 67-71.
23. 23 Valanzano R, Cama A, Volpe R, Curia MC, Mencucci R, Palmirotta R, et al.: Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis: novel criteria of assessment and correlations with constitutional adenomatous polyposis coli gene mutations. Cancer 1996, 78:2400-2410.
24. 24 Parker JA, Berk T, Bapat BV: Familial variation in retinal pigmentation in adenomatous polyposis. Can J Ophthalmol 1995, 30:138-141.
25. 25 Heyen F, Jagelman DG, Romania A, Zakov ZN, Lavery IC, Fazio VW, McGannon E: Predictive value of congenital hypertrophy of the retinal pigment epithelium as a clinical marker for familiat adenomatous polyposis. Dis Colon Rectum 1990, 33:1003-1008.
26. 26 Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al.: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:589-600.
27. 27 Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, et al.: Identification of FAP locus genes from chromosome 5q21. Science 1991, 253:661-665.
28. 28 Caspari R, Friedl W, Boker T, Augustin A, Mandl M, Jaeger K, et al.: Predictive diagnosis in familial adenomatous polyposis: evaluation of molecular genetic and ophthalmologic methods. Z Gastroenterol 1993, 31:646-652.
29. 29 Wallis YL, Macdonald F, Hulten M, Morton JEV, McKeown CM, Neoptolemos J, et al.: Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis. Hum Genet 1994, 94:543-54B.
30. 30 Reck AC, et al.: The presence of congenital hypertrophy of the retinal pigment epithelium in a subgroup of patients with adenomatous polyposis coli mutations. Eye 1997, 11 (part 3):298-300.
31. 31 Pack K, Smith-Ravin J, Phillips RKS, Hodgson SV: Exceptions to the rule: individuals with FAP specific CHRPE and mutations in exon 6 of the APC gene. Clin Genet 1996, 50:110-111.